'We literally save lives on a weekly basis': Everlab raises $15m for global push
The Melbourne startup is looking to expand its AI-powered health platform, aiming to make life-saving, preventive care more accessible in Australia and beyond.
One in four Australians undergoing comprehensive health testing through Everlab receive abnormal results. For 2.5% of members, the findings are life-changing — blocked arteries, brain aneurysms or early-stage cancers that would have had just a 10% survival rate if detected later.
These sobering statistics underpin the rapid growth of the Melbourne-based health startup, which today announced a USD10 million ($15.3 million) seed round led by global growth equity firm Left Lane Capital, as it prepares to enter competitive international markets.
"We literally save lives on a weekly basis," said co-founder and CEO Marc Hermann, whose personal tragedy sparked the company's mission.
"Our CMO brings the top clinical cases of the week into our weekly retro meetings. We catch arterial blockages in the heart, aneurysms in the brain, early stage cancers that would have been down to 10% survival rate if they wouldn't have been caught."
